138 related articles for article (PubMed ID: 17447051)
1. Time-dependent decreases in apparent pA2 values for naltrexone studied in combination with morphine in rhesus monkeys.
Gerak LR; France CP
Psychopharmacology (Berl); 2007 Aug; 193(3):315-21. PubMed ID: 17447051
[TBL] [Abstract][Full Text] [Related]
2. Comparison of naltrexone, 6alpha-naltrexol, and 6beta-naltrexol in morphine-dependent and in nondependent rhesus monkeys.
Li JX; McMahon LR; France CP
Psychopharmacology (Berl); 2008 Jan; 195(4):479-86. PubMed ID: 17874317
[TBL] [Abstract][Full Text] [Related]
3. Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone.
France CP; de Costa BR; Jacobson AE; Rice KC; Woods JH
J Pharmacol Exp Ther; 1990 Feb; 252(2):600-4. PubMed ID: 2156055
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), buprenorphine and methadone in morphine-treated rhesus monkeys.
Brandt MR; Cabansag SR; France CP
J Pharmacol Exp Ther; 1997 Aug; 282(2):574-84. PubMed ID: 9262317
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus and antinociceptive effects of dihydroetorphine in rhesus monkeys.
Gerak LR; Gauthier CR; France CR
Psychopharmacology (Berl); 2003 Apr; 166(4):351-9. PubMed ID: 12601499
[TBL] [Abstract][Full Text] [Related]
6. The discriminative stimulus effects of naloxone and naltrexone in morphine-treated rhesus monkeys: comparison of oral and subcutaneous administration.
Gauthier CA; France CP
Psychopharmacology (Berl); 1999 May; 144(2):131-6. PubMed ID: 10394993
[TBL] [Abstract][Full Text] [Related]
7. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
[TBL] [Abstract][Full Text] [Related]
8. Interaction of morphine and naltrexone on oral ethanol self-administration in rhesus monkeys.
Williams KL; Kane EC; Woods JH
Behav Pharmacol; 2001 Sep; 12(5):325-33. PubMed ID: 11710747
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys.
Bowen CA; Fischer BD; Mello NK; Negus SS
J Pharmacol Exp Ther; 2002 Jul; 302(1):264-73. PubMed ID: 12065726
[TBL] [Abstract][Full Text] [Related]
10. Self-administration of cocaine-heroin combinations by rhesus monkeys: antagonism by naltrexone.
Rowlett JK; Wilcox KM; Woolverton WL
J Pharmacol Exp Ther; 1998 Jul; 286(1):61-9. PubMed ID: 9655842
[TBL] [Abstract][Full Text] [Related]
11. Effects of heroin and its metabolites on schedule-controlled responding and thermal nociception in rhesus monkeys: sensitivity to antagonism by quadazocine, naltrindole and beta-funaltrexamine.
Negus SS; Brandt MR; Gatch MB; Mello NK
Drug Alcohol Depend; 2003 May; 70(1):17-27. PubMed ID: 12681522
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys.
France CP; Woods JH
J Pharmacol Exp Ther; 1989 Sep; 250(3):937-43. PubMed ID: 2550623
[TBL] [Abstract][Full Text] [Related]
13. Antagonist-precipitated and discontinuation-induced withdrawal in morphine-dependent rhesus monkeys.
Becker GL; Gerak LR; Koek W; France CP
Psychopharmacology (Berl); 2008 Dec; 201(3):373-82. PubMed ID: 18726088
[TBL] [Abstract][Full Text] [Related]
14. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
Walker EA; Makhay MM; House JD; Young AM
J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey.
White DA; Holtzman SG
Psychopharmacology (Berl); 2003 May; 167(2):203-10. PubMed ID: 12644889
[TBL] [Abstract][Full Text] [Related]
16. Interactions between Delta(9)-tetrahydrocannabinol and mu opioid receptor agonists in rhesus monkeys: discrimination and antinociception.
Li JX; McMahon LR; Gerak LR; Becker GL; France CP
Psychopharmacology (Berl); 2008 Aug; 199(2):199-208. PubMed ID: 18470505
[TBL] [Abstract][Full Text] [Related]
17. In vivo activation of a mutant mu-opioid receptor by naltrexone produces a potent analgesic effect but no tolerance: role of mu-receptor activation and delta-receptor blockade in morphine tolerance.
Roy S; Guo X; Kelschenbach J; Liu Y; Loh HH
J Neurosci; 2005 Mar; 25(12):3229-33. PubMed ID: 15788780
[TBL] [Abstract][Full Text] [Related]
18. Studies on benzodiazepines and opioids administered alone and in combination in rhesus monkeys: ventilation and drug discrimination.
Gerak LR; Brandt MR; France CP
Psychopharmacology (Berl); 1998 May; 137(2):164-74. PubMed ID: 9630003
[TBL] [Abstract][Full Text] [Related]
19. Effects of Daily Methocinnamox Treatment on Fentanyl Self-Administration in Rhesus Monkeys.
Maguire DR; France CP
J Pharmacol Exp Ther; 2022 Aug; 382(2):181-187. PubMed ID: 35643857
[TBL] [Abstract][Full Text] [Related]
20. Relative efficacy of buprenorphine, nalbuphine and morphine in opioid-treated rhesus monkeys discriminating naltrexone.
Sell SL; McMahon LR; France CP
J Pharmacol Exp Ther; 2003 Sep; 306(3):1167-73. PubMed ID: 12766254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
